Skip to main content
. 2019 May 22;4(4):748–752. doi: 10.1016/j.adro.2019.05.004

Figure 3.

Figure 3

(a) Mean cell-free DNA concentration during various phlebotomy time points before, during, and after chemoradiation therapy. ** Significance in the change in cell-free DNA concentration from the baseline to the 6-week posttreatment follow-up samples. (b) Detected mutated genes are indicated in the frequency histogram; type of mutation is superimposed in color. (c) Qualitative plot of mutations in circulating tumor DNA. Each column represents a unique patient.